Amer Sports Q2: Salomon Enters Rapid Growth Mode

Amer Sports (NYSE:AS) reported robust Q2 results, exceeding expectations with 23% revenue growth and strong margin expansion, prompting its second 2025 guidance raise. This performance was largely attributed to the rapid growth of its Salomon and Arc'teryx brands, alongside a successful shift towards direct-to-consumer channels, particularly through store expansion in China. However, an analyst suggests that the company's rapid growth trajectory is already factored into the stock's valuation, estimating a fair value of $38.6 per share.

Analysis

Amer Sports, Inc. (AS) reported a strong second-quarter performance, characterized by a 23% revenue growth and significant margin gains, resulting in a beat on key metrics and a second upward revision to its 2025 guidance. This operational strength is primarily driven by accelerating consumer interest in its core brands, with Salomon now joining Arc'teryx in a phase of rapid growth. The company's margin expansion is a direct result of a successful strategic shift in its channel mix towards direct-to-consumer (DTC), which has been fueled by targeted store expansion, particularly in China. Despite the robust fundamentals and positive outlook, the accompanying analysis posits that this growth trajectory is already fully reflected in the stock's valuation, with a specific fair value estimate of $38.6 per share, suggesting limited near-term appreciation potential.

Key Decisions for Investors

• Given the analyst's view that the stock is fairly valued at $38.6, investors considering a new position should weigh the strong operational momentum against the risk that future growth is already priced in.
• Existing shareholders should closely monitor the continued performance of the Salomon and Arc'teryx brands, as their sustained high growth is essential to supporting the current valuation.
• The success of the direct-to-consumer expansion in China is a critical factor for margin sustainability; any slowdown in this strategic shift could present a risk to the company meeting its raised guidance.
• Investors should note the divergence between the highly positive operational results and the neutral valuation call, indicating that the primary risk is valuation de-rating rather than fundamental weakness.